Seed loss through the urinary tract and retrieval after prostate seed implant

Nippon Acta Radiologica

Volumn 65, Issue 3, 2005, Pages 263-265

  Yorozu, Atsunori ^a   Toya, Kazuhito ^a   Ohashi, Toshio ^a   Monma, Tetsuo ^a   Saito, Shiro ^a  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

Brachytherapy; Iodine 125; Prostate carcinoma; Seed loss

Indexed keywords

RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BRACHYTHERAPY; CHEMISTRY; HUMAN; MALE; PROSTATE TUMOR; URINARY TRACT;

BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; URINARY TRACT;

EID: 26944485195     PISSN: 00480428     EISSN: 13477951     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Prestidge BR, Prete JJ, Buchholz TA, et al: A survey of current clinical practice of permanent prostate brachytherapy in the United States. Int J Radiat Oncol Biol Phys 40: 461-465, 1998
2. Stutz M, Petrikas J, Raslowsky M, et al: Seed loss through the urinary tract after prostate brachytherapy: examining the role of cystoscopy and urine straining post implant. Med Phys 30: 2695-2698, 2003
3. Stone NN, Stock RG: Dynamic cystography can replace cystoscopy following prostate seed implantation.